Candidates | Company |
Forxiga (Dapagliflozin) | AstraZeneca |
Viekira Pak (Ombitasvir) | Abbvie |
Lynparza (Olaparib) | AstraZeneca |
Otezla (Apremilast) | Celgene |
Forsteo (Teriparatide) | Lilly |
Imbruvica (Ibrutinib) | Janssen |
Trulicity (Dulaglutide) | Lilly |
Candidates | Company |
Evolocumab (Repata) | Amgen |
Yervoy (Ipilimumab) | Bristol-Myers Squibb |
Sovriad (Simeprevir) | Janssen |
Beyodaim (Pertuzumab+Trastuzumab) | Roche |
Zelboraf (Vemurafenib) | Roche |
Candidates | Company |
Opsumit (Macitentan) | Actelion |
BLINATUMOMAB | Amgen |
Candidates | Company |
Absorb™ Bioresorbable Vascular Scaffold | Abbott |
Johnson & Johnson – OneTouch Verio® IQ | Johnson & Johnson |
Candidates | Company |
Nanoencapsulated colistin | BIND |
Triazavirin | Institute of Organic Synthesis |
Mobilan Mobilan (M-VM3) | Panacela Labs |
Candidates | Company |
“Femoflor®”+ “ImmunoQuantex®” | DNA |
Triazavirin | Institute of Organic Synthesis |
Seroguard | Pharmasyntez |